Literature DB >> 21308536

Clinical trial report: treatment of cryptococcal meningitis in the developing world.

Allan R Tunkel1.   

Abstract

Entities:  

Year:  2010        PMID： 21308536     DOI： 10.1007/s11908-010-0107-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  10 in total

1.  Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.

Authors:  C M van der Horst; M S Saag; G A Cloud; R J Hamill; J R Graybill; J D Sobel; P C Johnson; C U Tuazon; T Kerkering; B L Moskovitz; W G Powderly; W E Dismukes
Journal:  N Engl J Med       Date:  1997-07-03       Impact factor: 91.245

2.  Cryptococcosis in the developing world: an elephant in the parlor.

Authors:  Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

3.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

4.  Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

Authors:  A C Leenders; P Reiss; P Portegies; K Clezy; W C Hop; J Hoy; J C Borleffs; T Allworth; R H Kauffmann; P Jones; F P Kroon; H A Verbrugh; S de Marie
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

5.  Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.

Authors:  R A Larsen; M A Leal; L S Chan
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

6.  Successful use of amphotericin B lipid complex in the treatment of cryptococcosis.

Authors:  Larry M Baddour; John R Perfect; Luis Ostrosky-Zeichner
Journal:  Clin Infect Dis       Date:  2005-05-01       Impact factor: 9.079

7.  Cryptococcosis in the acquired immunodeficiency syndrome.

Authors:  J A Kovacs; A A Kovacs; M Polis; W C Wright; V J Gill; C U Tuazon; E P Gelmann; H C Lane; R Longfield; G Overturf
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

8.  Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.

Authors:  P K Sharkey; J R Graybill; E S Johnson; S G Hausrath; R B Pollard; A Kolokathis; D Mildvan; P Fan-Havard; R H Eng; T F Patterson; J C Pottage; M S Simberkoff; J Wolf; R D Meyer; R Gupta; L W Lee; D S Gordon
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

9.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

Authors:  A Zuger; E Louie; R S Holzman; M S Simberkoff; J J Rahal
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

10.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.